XRTX XORTX Therapeutics Inc.

Nasdaq xortx.com


$ 0.55 $ 0.00 (-0.43 %)    

Friday, 14-Nov-2025 15:35:13 EST
QQQ $ 608.45 $ 0.46 (0.08 %)
DIA $ 471.65 $ -2.94 (-0.62 %)
SPY $ 671.62 $ -0.11 (-0.02 %)
TLT $ 88.93 $ -0.51 (-0.57 %)
GLD $ 375.82 $ -6.91 (-1.8 %)
$ 0.5567
$ 0.56
$ 0.54 x 1,100
$ 0.55 x 500
$ 0.54 - $ 0.55
$ 0.53 - $ 1.79
61,572
na
2.11M
$ 4.07
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU))), a late stage cli...

Core News & Articles

Gainers Galecto (NASDAQ: GLTO) stock rose 21.6% to $5.41 during Thursday's after-market session. The market value of their...

 xortx-therapeutics-issues-73871-shares-at-154-in-q1-2025-raising-net-proceeds-of-1097k-under-atm-program

Issuance of Shares under ATM OfferingIn other news, the Company confirms the issuance of 73,871 common shares at US$1.54 (CAD $...

Core News & Articles

XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU))), a late stage cli...

Core News & Articles

XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU))), a late stage cli...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION